Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Interim Management Statement

28 Jul 2009 07:00

RNS Number : 3605W
Charles Stanley Group PLC
28 July 2009
 



INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 30 JUNE 2009

As the Chairman will advise shareholders at today's Annual General Meeting, Charles Stanley Group PLC is pleased to announce that its revenue for the three months to 30 June 2009, the first quarter of its financial year 2009-10, was 2.4% higher, at £26.0 million, than the comparable figure of £25.4 million for the three months to 30 June 2008

Since 31 March 2009 the business has performed solidly in markets that continue to be challenging. Income has been resilient across all three divisions and we have strengthened the securities division with a number of new hires.

Total client funds under investment management or administration rose during the quarter by 10.0% from £9.0 billion at 31 March 2009 to £9.9 billion at 30 June 2009. Within this figure the funds under discretionary management increased by 11.1% from £2.7 billion to £3.0 billion. For the same period, the FTSE 100 strengthened by 8.3% from 3926 to 4249 and the FTSE APCIMS Balanced Portfolio Index by 3.9%.

It is difficult to predict how much longer the current conditions will prevail. However, with a strong balance sheet Charles Stanley is well placed to take advantage of further acquisition opportunities.

Quarter ended 30 June 2009

Private Clients

 £'000

Financial Services

£'000

Charles Stanley Securities

£'000

Total

 

£'000

Commission

11,893

8

2,206

14,107

Fees

Investment Management

5,108

51

-

5,159

Administration

4,035

2,123

-

6,158

Corporate Finance

-

-

543

543

Other

-

-

-

71

Total

21,036

2,182

2,749

26,038

 

30 June 2009

31 March 2009

Change

£bn

£bn

%

Discretionary funds under management

3.0

2.7

11.1%

Advisory funds under management

2.0

1.9

5.3%

Total funds under management 

5.0

4.6

8.7%

Advisory dealing funds

2.1

2.0

5.0%

Execution only funds

2.8

2.4

16.7%

Total administered funds

4.9

4.4

11.4%

Total funds under management and administration

9.9

9.0

10.0%

For further information please contact

Charles Stanley Group PLC Canaccord Adams Ltd

Peter Hurst, Director  Simon Bridges

Michael Lilwall, Director Phone: 020 7050 6500

Magnus Wheatley, Head of Press & Public Relations Oriel Securities Ltd

Phone: 020 7149 6273 Tom Durie

Email: magnus.wheatley@charles-stanley.co.uk Phone: 020 7710 7600

Notes for editors

Charles Stanley Group PLC has four trading companies, Charles Stanley & Co. Limited, EBS Management plc, Griffiths & Armour (Financial Services) Limited and Garrison Investment Analysis Limited. 

Charles Stanley & Co. Limited provides full-service stockbroking, financial planning and benefit consultancy and small and mid cap advisory and institutional broking. 

EBS Management plc provides specialist pensions administration services.

Griffiths & Armour (Financial Services) Limited is a specialist provider of corporate employee benefits services.

Garrison Investment Analysis Limited markets unit trusts, open-ended investment company units and packaged financial products to private clients, both directly and in wrappers such as ISAs and pensions.

All four trading companies are regulated by the Financial Services Authority. The Group has 32 offices around the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZGGZNVNLGLZM
Date   Source Headline
18th Dec 20199:16 amRNSDirector/PDMR Shareholding
13th Dec 201910:28 amRNSDirector/PDMR Shareholding
11th Dec 20192:10 pmRNSHolding(s) in Company
11th Dec 20199:30 amRNSHolding(s) in Company
10th Dec 20194:16 pmRNSHolding(s) in Company
29th Nov 201910:39 amRNSTotal Voting Rights
25th Nov 201911:33 amRNSInterim Results Correction Notice
21st Nov 20193:07 pmRNSAppointment of External Auditor
21st Nov 20197:00 amRNSInterim Results
20th Nov 201911:28 amRNSHolding(s) in Company
11th Nov 201910:10 amRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSNotice of Interim Results
31st Oct 20199:56 amRNSTotal Voting Rights
22nd Oct 20192:26 pmRNSHolding(s) in Company
11th Oct 20191:21 pmRNSDirector/PDMR Shareholding
11th Oct 20199:43 amRNSTR-1 NOTIFICATION
30th Sep 201911:35 amRNSTotal Voting Rights
20th Sep 20193:42 pmRNSDirector Declaration
13th Sep 20191:03 pmRNSDirector/PDMR Shareholding
30th Aug 201912:15 pmRNSTotal Voting Rights
9th Aug 201912:44 pmRNSDirector/PDMR Shareholding
1st Aug 20199:00 amRNSAcquisition
31st Jul 20199:58 amRNSTotal Voting Rights
26th Jul 201912:30 pmRNSDirector/PDMR Shareholding
26th Jul 201912:13 pmRNSHolding(s) in Company
18th Jul 20194:05 pmRNSDirector/PDMR Shareholding
18th Jul 201911:23 amRNSBlock Listing Application
15th Jul 20193:34 pmRNSHolding(s) in Company
12th Jul 201911:43 amRNSDirector/PDMR Shareholding
11th Jul 20197:00 amRNSResult of AGM
10th Jul 20197:00 amRNSTrading Update
4th Jul 20193:41 pmRNSHolding(s) in Company
1st Jul 20191:00 pmRNSTotal Voting Rights
27th Jun 20191:10 pmRNSBlock Listing Application
26th Jun 201912:46 pmRNSDirector/PDMR Shareholding
26th Jun 201912:43 pmRNSDirector/PDMR Shareholding
14th Jun 20191:08 pmRNSDirector/PDMR Shareholding
12th Jun 20191:15 pmRNSTR-1
10th Jun 20193:59 pmRNSAnnual Financial Report
31st May 201910:52 amRNSTotal Voting Rights
31st May 20197:00 amRNSResults for the year ended 31 March 2019
23rd May 201911:18 amRNSHolding(s) in Company
22nd May 201912:39 pmRNSDirectorate Change
13th May 201911:08 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSRestructure of Operating Model
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 201911:35 amRNSHolding(s) in Company
30th Apr 20193:07 pmRNSTotal Voting Rights
18th Apr 20194:36 pmRNSPrice Monitoring Extension
15th Apr 201911:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.